[
  {
    "ts": null,
    "headline": "Tracking William Nygren's Harris Associates Portfolio - Q1 2025 Update",
    "summary": "Harris Associates' Q1 2025 portfolio shifts reveal major stake changes in top stocks like ConocoPhillips and Airbnb.",
    "url": "https://finnhub.io/api/news?id=27f163a1217d670dd9241ea06700801ae7e6793a361618c884e18a408bcaf892",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750014900,
      "headline": "Tracking William Nygren's Harris Associates Portfolio - Q1 2025 Update",
      "id": 135287742,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1305621026/image_1305621026.jpg?io=getty-c-w1536",
      "related": "ELV",
      "source": "SeekingAlpha",
      "summary": "Harris Associates' Q1 2025 portfolio shifts reveal major stake changes in top stocks like ConocoPhillips and Airbnb.",
      "url": "https://finnhub.io/api/news?id=27f163a1217d670dd9241ea06700801ae7e6793a361618c884e18a408bcaf892"
    }
  },
  {
    "ts": null,
    "headline": "INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance Health",
    "summary": "Faruqi & Faruqi, LLP Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Elevance To Contact Him Directly To Discuss Their OptionsIf you...",
    "url": "https://finnhub.io/api/news?id=15645cd99c8ae17c152c5beec879d7740e5e45b193fa8bd0f86a22750ea6d6c9",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749982745,
      "headline": "INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance Health",
      "id": 135285323,
      "image": "",
      "related": "ELV",
      "source": "Finnhub",
      "summary": "Faruqi & Faruqi, LLP Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Elevance To Contact Him Directly To Discuss Their OptionsIf you...",
      "url": "https://finnhub.io/api/news?id=15645cd99c8ae17c152c5beec879d7740e5e45b193fa8bd0f86a22750ea6d6c9"
    }
  },
  {
    "ts": null,
    "headline": "Truist Lowers Elevance Health (ELV) to $500, Keeps Buy Rating",
    "summary": "Elevance Health Inc. (NYSE:ELV) is one of the 8 Best Inexpensive Stocks to Buy Right Now. On June 9, Truist analyst David MacDonald slightly reduced the firm’s price target on Elevance Health from $510 to $500, while maintaining a Buy rating on the shares. Despite the adjustment, the analyst remains positive on Elevance Health’s substantial […]",
    "url": "https://finnhub.io/api/news?id=a700995617c274dd0548cc8a301b40898bbd92991f7cd09aa4782ba576535318",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749980342,
      "headline": "Truist Lowers Elevance Health (ELV) to $500, Keeps Buy Rating",
      "id": 135284817,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ELV",
      "source": "Yahoo",
      "summary": "Elevance Health Inc. (NYSE:ELV) is one of the 8 Best Inexpensive Stocks to Buy Right Now. On June 9, Truist analyst David MacDonald slightly reduced the firm’s price target on Elevance Health from $510 to $500, while maintaining a Buy rating on the shares. Despite the adjustment, the analyst remains positive on Elevance Health’s substantial […]",
      "url": "https://finnhub.io/api/news?id=a700995617c274dd0548cc8a301b40898bbd92991f7cd09aa4782ba576535318"
    }
  }
]